期刊名称 | Expert Opinion on Drug Delivery EXPERT OPIN DRUG DEL |
---|---|
期刊ISSN | 1742-5247 |
期刊官方网站 | https://www.tandfonline.com/journals/iedd20 |
是否OA | No |
出版商 | Taylor and Francis Ltd. |
出版周期 | Bimonthly |
文章处理费 | 登录后查看 |
始发年份 | 2004 |
年文章数 | 103 |
影响因子 | 5.0(2023) scijournal影响因子 greensci影响因子 |
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | PHARMACOLOGY & PHARMACY 药学2区 | 否 | 是 |
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 11.1 | 1.009 | 1.090 |
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
13/183 | 93% |
自引率 | 4% |
---|---|
H-index | 88 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5247%5BISSN%5D |
期刊投稿网址 | https://mc.manuscriptcentral.com/eodd |
---|---|
收稿范围 | Expert Opinion on Drug Delivery (1742-5247; 1744-7593) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug delivery. Articles cover all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The journal welcomes: Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders Technology evaluations reviewing a particular drug delivery technology Original research contributions are welcomed in the form of: - Delivery technologies, vehicles, formulations and devices; - The delivery of specific drugs and therapeutic classes; - Modes of entry into the body and applications in certain diseases and disorders. Editorials commenting on the various drug delivery strategies which have been, and are being, explored Guidelines on the application of specific drug delivery systems, or in specific disease indications. The audience for the journal consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents. Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Publish in 3 weeks from submission with Accelerated Publication. Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Delivery, part of the Expert Collection brand. |
收录体裁 | |
投稿指南 | https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=iedd20 |
投稿模板 | |
参考文献格式 | |
编辑信息 |
|